Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Profiles
Research Units
Equipment
Projects
Research Output
Prizes
Activities
Press / Media
Search by expertise, name or affiliation
A randomised, double-blind, placebo-controlled multi centre phase III study of regorafenib in patients with hepatocellular carcinoma (HCC) after sorafenib
Lubel, John
(Primary Chief Investigator (PCI))
Eastern Health Clinical School
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
31/05/13
→
23/10/14
View all
View less